Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
21-24 October, 2025
AllPack IndonesiaAllPack Indonesia
Not Confirmed
Not Confirmed
21-25 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
21-24 October, 2025
AllPack IndonesiaAllPack Indonesia
Industry Trade Show
Not Confirmed
21-25 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

17 Sep 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/skyhawk-therapeutics-announces-positive-first-interim-results-in-patients-from-its-phase-1-clinical-trial-of-sky-0515-as-a-treatment-for-huntingtons-disease-302559083.html

19 Aug 2025
// PRESS RELEASE
https://www.skyhawktx.com/post/skyhawk-therapeutics-announces-strategic-collaboration-with-merck-kgaa-darmstadt-germany-to-discov

17 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/skyhawk-therapeutics-announces-first-patient-dosed-in-phase-23-falcon-hd-trial-of-sky-0515-for-huntingtons-disease-302483907.html

09 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/skyhawk-therapeutics-receives-australian-regulatory-approval-to-extend-sky-0515-treatment-duration-in-phase-1-huntingtons-disease-patient-trial-302326386.html

24 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/skyhawk-therapeutics-presents-compelling-preclinical-data-on-sky-1214-at-the-eortc-nci-aacr-molecular-targets-and-cancer-therapeutics-symposium-302285986.html

11 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/skyhawk-therapeutics-to-present-additional-positive-topline-data-from-parts-a-and-b-of-phase-1-clinical-trial-of-sky-0515-at-european-huntingtons-disease-network-and-enroll-hd-2024-302244451.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE